logo-loader
viewChampignon Brands Inc.

Champignon Brands to raise $10 million for North American ketamine clinic expansion

The Vancouver-based company plans to open at least five new ketamine clinics in the US by the end of 2020

Champignon Brands Inc. -
Champignon is offering 11,765,000 units priced at $0.85 per unit for total gross proceeds of $10,000,250

Champignon Brands Inc (CSE:SHRM), the psychedelic healthcare company, is raising $10 million to expand its North American clinical footprint.

The Vancouver-based company plans to open at least five new ketamine clinics in the US by the end of 2020.

Earlier this month, Champignon told shareholders it is in discussions with clinic operators in California, New York, Pennsylvania, Texas, Florida and Missouri.

READ: Champignon Brands appoints psychiatry and pharmacology professor, Roger McIntyre as new CEO

The offering also comes just after the firm announced that ketamine expert Dr Roger McIntyre is taking up the reins as its CEO.

McIntyre implemented and developed the Canadian Rapid Treatment Centre of Excellence (CRTCE), the country's first-ever rapid-onset treatment centre for persons with mood disorders.

In a deal led by co-lead underwriters Eight Capital and Canaccord Genuity, Champignon is offering 11,765,000 units priced at $0.85 per unit for total gross proceeds of $10,000,250. Each unit is comprised of one share and one half of one warrant exercisable at C$1.15 for a 24-month period following the closing date.

The firm said it has granted the underwriters an option to buy an additional 5.882,500 units at the issue price. The underwriters will receive a cash commission equal to 7% of the aggregate gross proceeds of the offering and warrants exercisable to acquire a number of units equal to 7% of the total units sold under the offering.

The offering is expected to close by June 11.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Champignon Brands Inc.

Price: 0.89 CAD

CSE:SHRM
Market: CSE
Market Cap: $70.54 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Champignon Brands Inc. named herein, including the promotion by the Company of Champignon Brands Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Champignon Brands charts course for success with acquisitions and a name change

Champignon Brands (CSE: SHRM- OTCQB: SHRMF) CEO Dr Roger McIntyre joined Steve Darling from Proactive Vancouver with news the company is changing its name to Apotheosis, which means the high point of development. McIntyre discusses the thinking behind the change, plus acquisitions and other...

2 weeks, 2 days ago

2 min read